In this video, Juan Alderuccio, MD, Sylvester Comprehensive Cancer Center, Miami, FL, briefly comments on a study elucidating that epcoritamab combined with R-CHOP overcomes the poor risk feature of high total metabolic tumor volume in patients with high-risk large B-cell lymphoma (LBL). This presents a promising therapeutic approach for this patient population. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

свернуть